In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioInvent International AB

www.bioinvent.com

Latest From BioInvent International AB

Merrimack Pharma Cutting Jobs Again After Shelving Third Cancer Drug In Year

Merrimack Pharmaceuticals is ending development of its lead drug MM-310 because of safety concerns, triggering a fresh round of job cuts at the troubled Cambridge, Massachusetts-based biotech.

Clinical Trials Drug Safety

BioInvent CEO To Step Down And Seek Scientific Successor

With its focus firmly on oncology, the Swedish biotech, and its outgoing chief, believe the company now needs someone with more scientific skills in the CEO role.

Leadership Sales & Earnings

Deal Watch: Inventiva Expands Collaborations With Boehringer, AbbVie

French biotech expands fibrosis partnership with Boehringer Ingelheim, and a co-development pact with AbbVie around ROR gamma inverse agonists. Helsinn signs on to detail Novartis' Zykadia in the US.

Deals M & A

BioInvent CEO On Pfizer Immunotherapy Alliance

Three years after setting out to turnaround BioInvent, company president & CEO Michael Oredsson explains how the company is developing its immunotherapy offering. With tumor associated myeloid cells, BioInvent secured a deal with Pfizer at the end of 2016, while it intends to go it alone with its regulatory T-cell approach.

ImmunoOncology Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • BioInvent International AB
  • Senior Management
  • Michael Oredsson, Pres. & CEO
    Bjorn Frendeus, PhD, CSO
    Anna Wickenberg, PhD, VP, Clinical Dev.
  • Contact Info
  • BioInvent International AB
    Phone: (46) 46 286 85 50
    Ideon Science Park
    Lund, SE-223 70
    Sweden
UsernamePublicRestriction

Register